Medicines and Tax Notices




28 MAY NEW ZEALAND GAZETTE 1647

Dated this 25th of May 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go3656

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Enoxaparin sodium 100 mg/mL Injection, ampoule and pre-filled syringe Rhone-Poulenc Rorer Pharma Specialites, Maisons-Alfort, France Clexane
Ganciclovir 250 mg Capsule, powder filled Syntex Puerto Rico Inc., Humacao, Puerto Rico and Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom Cymevene
Benzydamine hydrochloride 10 mg/g, cetylpyridinium chloride 1 mg/g Gel, oral 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Difflam Anti-inflammatory Anti-septic Mouth Gel
Fluticasone propionate 25 µg/dose, 50 µg/dose Inhaler, aerosol, metered Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia; Glaxo Wellcome, Ware, Hertfordshire, United Kingdom; Glaxo Wellcome Production, Evreux, France and Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom Flixotide
Cladribine 1 mg/mL Infusion, solution Janssen Pharmaceutica Inc., Fort Washington, Pennsylvania, United States of America and OMI Pharmaceuticals Inc., San German, Puerto Rico Leustatin
Itraconazole 10 mg/mL Solution, oral Janssen Pharmaceutica nv., Beerse, Belgium Sporanox
Fexofenadine hydrochloride 120 mg, 180 mg Tablets Hoechst Marion Roussel Inc., Kansas City, Missouri, United States of America Telfast
Lisinopril dihydrate 5.45 mg, 10.89 mg, 21.78 mg, equivalent to 5 mg, 10 mg, 20 mg lisinopril Tablets Zeneca Pharma, La Pomplelle, Reims, France and Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zestril
Goserelin acetate 3.6 mg Implant, subcutaneous Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zoladex Injectable Implant

Dated this 19th day of May 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go3545

Inland Revenue

Income Tax Act 1994

National Average Market Values of Specified Livestock Determination 1998

This determination may be cited as “The National Average Market Values of Specified Livestock Determination, 1998”.

This determination is made in terms of section EL 8 (1) of the Income Tax Act 1994 and shall apply to specified livestock on hand at the end of the 1997–98 income year.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 74


NZLII PDF NZ Gazette 1998, No 74





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
19 May 1998
Medicines, distribution, consent, changed medicines, Medicines Act 1981
  • G. R. Boyd, Chief Advisor, Regulation and Safety

💰 National Average Market Values of Specified Livestock Determination 1998

💰 Finance & Revenue
Income Tax, livestock, market values, determination, 1997-98 income year